Episodic Ataxia Type 5

Neurology

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Episodic Ataxia Type 5?

There are 1 clinical trial targeting Episodic Ataxia Type 5 tracked by BioSniper.

What is the prevalence of Episodic Ataxia Type 5?

The estimated prevalence of Episodic Ataxia Type 5 is approximately 0.1 per 100,000 population.

Deep-dive into Episodic Ataxia Type 5

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Episodic Ataxia Type 5 — Drugs in Development & Clinical Trials | BioSniper